The antibody crosses blood–brain barrier (BBB) at the efficiency of 2–8% antibody concentration ratio from plasma to cerebral cortex tissue (Tanaka, H. et al. HMGB1 signaling phosphorylates Ku70 and impairs DNA damage repair in Alzheimer’s disease pathology. Here, HMGB1 is linked to Alzheimer disease.